JENNA NAZMINIA: Open Payments
NPI 1265049522 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 26 payments from 12 companies in 2025. Trend: 2023 $441 · 2024 $839 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $94 |
| Lilly USA, LLC | 5 | $88 |
| Exact Sciences Corporation | 3 | $65 |
| Amgen Inc. | 3 | $46 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| SANOFI PASTEUR INC. | 1 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Dexcom, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
Products named: Wegovy, MOUNJARO, OTEZLA, Cologuard Collection Kit, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, JARDIANCE, Dexcom G6 Transmitter, Rybelsus.
Industry payments across TX — which companies pay providers there.
